Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Mallinckrodt offloads CDMO for $250m

Move follows US opioid settlement

- PMLiVE

Merck takes evobrutinib for MS into phase 3, on mixed data

First drug in class to reach this stage for the illness

Synergy Vision completes pilot of four-day working week

Agency will formalise the initiative following improved productivity

- PMLiVE

The power of high-value, highly relevant content to support clinical decisions

by Sandrine Veillet

Spotlight interview: 15 minutes on patient-centricity in pharma

Sumira Riaz, Health Psychologist at OPEN Health Patient & Brand Communications, takes 15 minutes to answer some key questions on patient-centricity in pharma.

OPEN Health

- PMLiVE

Novartis’ CAR-T Kymriah scores SMC approval

Will now be available on NHS across the UK

- PMLiVE

Boehringer bags FDA OK for Ofev in rare lung disease ILD

First drug approved for condition

- PMLiVE

Prescription drug dependence ‘linked to deprivation’, says PHE

Public Health England publishes review on prescription rates

- PMLiVE

Breaking free

Pharma’s ability to understand and modify customer behaviour is improving – but is it doing enough?

AstraZeneca AZ

Can AZ’s Imfinzi challenge Tecentriq in small cell lung cancer?

New data shows improvement in overall survival

- PMLiVE

Lucid Group Lucky Lunches prove a spellbinding hit this summer

Lucid Group Lucky Lunches have been running throughout the summer months, giving our teams the chance to network and connect outside of the office - as well as enjoying a...

Lucid Group Communications Limited

bear in mirror

Money, money, money

Could it be, that money isn't everything afterall? Surely not.

Page & Page Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links